Errui Xinyue

Errui Xinyue is a biotechnology company that develops early diagnosis technology for neurodegenerative diseases utilizing advanced exosome-based methodologies. Operating within the broader healthcare and life sciences sectors, the organization focuses on creating innovative diagnostic solutions aimed at identifying complex neurological conditions long before advanced clinical symptoms begin to manifest in patients. By leveraging the unique structural properties of exosomes as reliable biological markers, the firm seeks to improve long-term clinical outcomes through more accurate, non-invasive, and timely screening processes for individuals at high risk of severe cognitive decline. The enterprise addresses a critical diagnostic gap in the current medical landscape by advancing specialized testing frameworks that actively support healthcare providers in monitoring and managing progressive neurodegenerative disorders. Errui Xinyue was established by founder Naxin Yao to commercialize these specialized biomedical diagnostic technologies for the broader medical market.